Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine candidates to prevent ...

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold. Regulators stopped testing last month as ...

Novavax can move forward with a trial ... Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine by the end of the year. Write to Ben Glickman at ben ...

Here’s what to know about the 2024-2025 vaccines — what’s available, how the updated versions are tested, how well each protects you, side effects and other safety information, the best time to get ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Novavax (NVAX) announced that the first participants have been dosed in its COVID-19-Influenza Combination and stand-alone seasonal influenza ...

Vernon Bernardino, an analyst from H.C. Wainwright, maintained the Buy rating on Novavax (NVAX – Research Report). The associated price target ...

The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...

It was later granted full FDA approval in August 2021 for people ... or nausea throughout the rest of the body. Novavax: The Novavax was the fourth COVID vaccine to be administered in the U.S ...

This summary covers recent significant events in the health sector, including major deals, court decisions, new drug ...